- Enrollment
- —
- Started
- —
- Completion
- —
- Locations
- 0
- Countries
- 0
- Updated
- Jun 2026
Recruitment-status index
UnknownPeptide Trials.
Explore every peptide study grouped under unknown in the local registry snapshot. Check the source record before relying on recruitment status, because registry entries can change.
- Studies
- 232
- Recruiting
- 0
- Completed
- 0
- Results posted
- 1
- Countries
- 44
- Avg enrollment
- 245
Velocity
Unknown trials by start year
Study start year · indexed snapshot
Development
Trials by phase
150phase labels
Early Phase 14
Phase 114
Phase 241
Phase 327
Phase 464
Industry
Leading sponsors
Jiangsu Hansoh Pharmaceutical Co., Ltd.2
SciClone Pharmaceuticals2
Amicus Therapeutics1
Bio Genuine (Shanghai) Biotech Co., Ltd.1
ChiRhoClin, Inc.1
Eli Lilly1
Hamad Medical Corporation1
HLB Pharmaceutical Co., Ltd.1
Therapeutic areas
Condition groups
Brain health5
Inflammation5
Pain5
Type 2 diabetes5
Weight loss5
Longevity3
Study explorer
Search this collection.
232 matching studies
Last registry update first
- Enrollment
- —
- Started
- —
- Completion
- —
- Locations
- 1
- Countries
- 1
- Updated
- Feb 2026
- Enrollment
- —
- Started
- —
- Completion
- —
- Locations
- 0
- Countries
- 0
- Updated
- Jul 2025
- Enrollment
- 1,792
- Started
- Feb 2008
- Completion
- —
- Locations
- 460
- Countries
- 4
- Updated
- May 2025
- Enrollment
- —
- Started
- —
- Completion
- —
- Locations
- 0
- Countries
- 0
- Updated
- Feb 2025
- Enrollment
- 126
- Started
- Aug 2024
- Completion
- Aug 2025
- Locations
- 1
- Countries
- 1
- Updated
- Aug 2024
- Enrollment
- 51
- Started
- Mar 2024
- Completion
- Aug 2025
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2024
- Enrollment
- 70
- Started
- Nov 2022
- Completion
- Dec 2024
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2024
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
ExenatideDulaglutideLixisenatideAlbiglutideBangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic DisordersType2diabetes
- Enrollment
- 938
- Started
- Sep 2024
- Completion
- Jun 2025
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2024
- Enrollment
- 90
- Started
- Mar 2019
- Completion
- Jul 2024
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2024
- Enrollment
- 90
- Started
- Jun 2024
- Completion
- Dec 2025
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2024
- Enrollment
- 99
- Started
- Feb 2022
- Completion
- Mar 2026
- Locations
- 2
- Countries
- 1
- Updated
- Jun 2024
- Enrollment
- 99
- Started
- Feb 2022
- Completion
- Jun 2026
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2024
Obstructive Sleep Apnoea and Cardiac Arrhythmias
NesiritideUniversity Hospitals Coventry and Warwickshire NHS TrustObstructive Sleep Apnea · Cardiovascular Diseases
- Enrollment
- 200
- Started
- Oct 2019
- Completion
- Apr 2025
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2024
Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention
NesiritideThe First Affiliated Hospital with Nanjing Medical UniversityVentricular Remodeling · Myocardial Infarction, Anterior Wall
- Enrollment
- 100
- Started
- May 2023
- Completion
- Feb 2025
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2024
- Enrollment
- 50
- Started
- Feb 2024
- Completion
- May 2024
- Locations
- 1
- Countries
- 1
- Updated
- Apr 2024
Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)
OctreotideUniversity Hospital, Basel, SwitzerlandNeuroendocrine Neoplasia's (NENs) · Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
- Enrollment
- 16
- Started
- Mar 2023
- Completion
- Dec 2025
- Locations
- 1
- Countries
- 1
- Updated
- Apr 2024
A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes
PramlintideMcGill University Health Centre/Research Institute of the McGill University Health Centretype1diabetes · Diabetes Mellitus, Type 1
- Enrollment
- 30
- Started
- Nov 2023
- Completion
- Jun 2025
- Locations
- 1
- Countries
- 1
- Updated
- Apr 2024
- Enrollment
- 65
- Started
- Sep 2024
- Completion
- Nov 2025
- Locations
- 0
- Countries
- 0
- Updated
- Apr 2024
- Enrollment
- 60
- Started
- Sep 2023
- Completion
- Dec 2024
- Locations
- 1
- Countries
- 1
- Updated
- Mar 2024
- Enrollment
- 30
- Started
- May 2012
- Completion
- Jun 2025
- Locations
- 1
- Countries
- 1
- Updated
- Mar 2024
Medication-related Osteonecrosis of the Jaw (MRONJ) Registry
TeriparatideAO Clinical Investigation and Publishing DocumentationMedication-related Osteonecrosis of the Jaw · Bisphosphonate-Associated Osteonecrosis of the Jaw
- Enrollment
- 518
- Started
- Aug 2017
- Completion
- Apr 2024
- Locations
- 14
- Countries
- 10
- Updated
- Mar 2024
Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion
DesmopressinChengdu University of Traditional Chinese MedicineLumbar Spondylolisthesis · Arthrosis; Spine
- Enrollment
- 126
- Started
- Mar 2024
- Completion
- Jun 2025
- Locations
- 0
- Countries
- 0
- Updated
- Mar 2024
PET/MR in Post Stroke Cardiac Inflammation Study
NesiritideLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sStroke · Inflammation
- Enrollment
- 12
- Started
- Jul 2023
- Completion
- Sep 2025
- Locations
- 1
- Countries
- 1
- Updated
- Mar 2024